TY - JOUR
T1 - Tratamento não farmacológico da angina refratária. Dispositivo de redução do seio coronário, uma nova alternativa terapêutica
AU - Madeira, Sérgio
AU - Brízido, Catarina
AU - Raposo, Luís
AU - Brito, João
AU - Vale, Nélson
AU - Leal, Sílvio
AU - Gonçalves, Pedro de Araújo
AU - Gabriel, Henrique Mesquita
AU - Teles, Rui Campante
AU - Almeida, Manuel
N1 - Publisher Copyright:
© 2021 Sociedade Portuguesa de Cardiologia
PY - 2021/5
Y1 - 2021/5
N2 - Refractory angina is defined as persistent angina (≥3 months) despite optimal medical and interventional therapies. It is increasing in frequency, due to the success of current medical and interventional therapies in improving the prognosis of coronary artery disease. Long‐term mortality is similar to that of patients with asymptomatic stable disease, but it affects patients’ quality of life, and has a significant impact on health care resources. Several therapeutic targets have been investigated, most with disappointing results. Many of the techniques have been abandoned because of lack of efficacy, safety issues, or economic and logistic limitations to wider applicability. The primary focus of this review is the coronary sinus Reducer, supporting evidence for which, although scarce, is promising regarding safety and efficacy in improving anginal symptoms and quality of life. It is also accessible to virtually all interventional cardiology departments.
AB - Refractory angina is defined as persistent angina (≥3 months) despite optimal medical and interventional therapies. It is increasing in frequency, due to the success of current medical and interventional therapies in improving the prognosis of coronary artery disease. Long‐term mortality is similar to that of patients with asymptomatic stable disease, but it affects patients’ quality of life, and has a significant impact on health care resources. Several therapeutic targets have been investigated, most with disappointing results. Many of the techniques have been abandoned because of lack of efficacy, safety issues, or economic and logistic limitations to wider applicability. The primary focus of this review is the coronary sinus Reducer, supporting evidence for which, although scarce, is promising regarding safety and efficacy in improving anginal symptoms and quality of life. It is also accessible to virtually all interventional cardiology departments.
KW - Coronary artery disease.
KW - Coronary sinus reducer device
KW - Non‐pharmacological antianginal therapy
KW - Refractory angina
KW - Coronary sinus reducer device
KW - Non‐pharmacological antianginal therapy
KW - Refractory angina
KW - Coronary artery disease
UR - http://www.scopus.com/inward/record.url?scp=85104281144&partnerID=8YFLogxK
U2 - 10.1016/j.repc.2020.09.005
DO - 10.1016/j.repc.2020.09.005
M3 - Review article
C2 - 33879377
AN - SCOPUS:85104281144
SN - 0870-2551
VL - 40
SP - 371
EP - 382
JO - Revista Portuguesa de Cardiologia
JF - Revista Portuguesa de Cardiologia
IS - 5
ER -